Karen H. Antman

Karen H. Antman is an American physician. She is the dean of Boston University School of Medicine and provost of the Boston University Medical Campus. Antman developed standards for the treatment of patients receiving chemotherapy including pharmacology, growth factors and mobilization of peripheral blood derived stem cells for blood and marrow transplant.

Her professional affiliations include serving on the Administration Board of the Association of American Medical Colleges Council of Deans, the ''Journal of the American Medical Association'' Oversight Committee, the International Editorial Board of ''Lancet'', and on the board of the Educational Commission for Foreign Medical Graduates (ECFMG). She was elected to the Institute of Medicine in 2011. Provided by Wikipedia